É. Rosenthal

发表

Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.

G. Hughes, M. Khamashta, P. Gordon, 2001, The Journal of rheumatology.

Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al.

G. Hughes, M. Khamashta, P. Gordon, 2001, Arthritis and rheumatism.

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13‐HEPAVIH cohort

M. Carrieri, B. Spire, P. Sogni, 2017, Addiction.

Obesity in Autoimmune Diseases

Y. Shoenfeld, P. Jeandel, É. Rosenthal, 2019, Mosaic of Autoimmunity.

Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients

K. Freedberg, Y. Yazdanpanah, A. Tran, 2008, Journal of acquired immune deficiency syndromes.

Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients

A. Pesce, J. Cassuto, É. Rosenthal, 1993, The Lancet.

Increased Time Exposure to Tenofovir Is Associated with a Greater Decrease in Estimated Glomerular Filtration Rate in HIV Patients with Kidney Function of Less than 60 ml/min/1.73 m2

V. Esnault, Jacques Durant, C. Pradier, 2012, Nephron Clinical Practice.

Extrahepatic manifestations in chronic hepatitis C virus carriers

P. Cacoub, É. Rosenthal, Patrice Cacoub, 2015, Lupus.

Introduction to the special issue on the 9th International Congress on Autoimmunity

Y. Shoenfeld, P. Jeandel, É. Rosenthal, 2014, Immunologic research.

Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010

P. Morlat, G. Geri, P. Cacoub, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Isolated Complete Heart Block in the Fetus.

J. Simpson, O. Miller, P. Gordon, 2015, The American journal of cardiology.

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)

P. Morlat, D. Costagliola, C. Lewden, 2008, Journal of acquired immune deficiency syndromes.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

D. Chauveau, J. Bussel, Z. Amoura, 2018, Rheumatology.

Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.

G. Hughes, J. Buyon, M. Khamashta, 2004, The Journal of rheumatology.

Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.

F. Dabis, M. Alvarez, J. Trinchet, 2012, Journal of hepatology.

Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.

J. Patel, P. Perre, P. Cacoub, 2009, Journal of acquired immune deficiency syndromes.

Eff ect of immunodefi ciency , HIV viral load , and antiretroviral therapy on the risk of individual malignancies ( FHDH-ANRS CO 4 ) : a prospective cohort study

M. Guiguet, É. Rosenthal, J. Cadranel, 2009 .

Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.

G. Kaplanski, C. Renou, P. Cacoub, 2001, Arthritis and rheumatism.

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

J. Piette, A. Camproux, L. Musset, 2000, Medicine.

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

J. Goedert, D. Costagliola, S. Grabar, 2013, AIDS.

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010

D. Neau, P. Morlat, F. Dabis, 2010, BMC infectious diseases.

Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.

P. Morlat, D. Costagliola, C. Lewden, 2009, Journal of hepatology.

P. Morlat, D. Costagliola, C. Lewden, 2009, HIV medicine.

Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.

D. Costagliola, S. Grabar, É. Rosenthal, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced incidence of kaposi's sarcoma and of systemic non‐hodgkin's lymphoma in HIV‐infected individuals treated with highly active antiretroviral therapy

D. Serraino, P. Piselli, M. Carrieri, 2003, International journal of cancer.

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.

D. Neau, P. Morlat, F. Dabis, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

V. de Lédinghen, F. Dabis, T. Allègre, 2017, Journal of acquired immune deficiency syndromes.

Wildo Navegantes de Araújo, M. Ziol, V. Paradis, 2019, AIDS and Behavior.

Phase IV Study of Liposomal Daunorubicin (DaunoXome) in AIDS-Related Kaposi Sarcoma

J. Spano, P. Cacoub, I. Poizot-Martin, 2002, American journal of clinical oncology.

Hepatitis C virus infection and lymphoproliferative diseases in France: A national study

D. Ouzan, P. Cacoub, É. Rosenthal, 2000 .

Eurosurveillance-View Article

D. Neau, S. Pol, G. Pialoux, 2008 .

Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections

R. López-Vélez, R. Russo, É. Rosenthal, 2003, Annals of tropical medicine and parasitology.

P. Morlat, D. Costagliola, G. Chêne, 2015, HIV medicine.

[Hepatitis C virus infection alone or associated with human immunodeficiency virus infection: comparison of two recent French survey].

P. Cacoub, É. Rosenthal, 2012, La Revue de medecine interne.

Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

P. Bedossa, S. Pol, P. Perre, 2009, Journal of acquired immune deficiency syndromes.

Co-infection par le virus de l’immunodéficience humaine et le virus de l’hépatite C

S. Pol, É. Rosenthal, P. Cacoub, 2008 .

Iconography : Prise en charge des patients co-infectés VIH-VHC

P. Cacoub, G. Pialoux, P. Halfon, 2007 .

Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients

J. Cassuto, É. Rosenthal, P. Marty, 2004, Bone Marrow Transplantation.

Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature.

P. Bastien, F. Pratlong, L. Lachaud, 2005, Microbes and infection.

Visceral leishmaniasis and HIV-1 co-infection in southern France.

F. Pratlong, O. Boulat, J. Dereure, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PLoS ONE.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PloS one.

Pregnancy and contraception in heart disease and pulmonary arterial hypertension

N. Panay, C. Nelson-Piercy, M. de Swiet, 2006, Journal of Family Planning and Reproductive Health Care.

Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients

D. Neau, P. Sogni, A. Gervais, 2019, Journal of acquired immune deficiency syndromes.

Immediate and long‐term survival in patients admitted to a respiratory ICU

P. Potgieter, É. Rosenthal, 1985, Critical care medicine.

[Adherence to pegylated combination therapy in patients with chronic hepatitis C. Importance of the hepatologist, general practitioner, and nurse].

V. de Lédinghen, T. Poynard, V. Ratziu, 2008, Gastroenterologie clinique et biologique.

Visceral leishmaniasis due to Leishmania infantumwith renal involvement in HIV-infected patients

P. Jeandel, É. Cassuto, É. Rosenthal, 2014, BMC Infectious Diseases.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

V. de Lédinghen, D. Neau, P. Morlat, 2019, PloS one.

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.

Y. Yazdanpanah, G. Peytavin, G. Pialoux, 2020, The Journal of antimicrobial chemotherapy.

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

C. Katlama, P. Morlat, F. Dabis, 2018, World journal of hepatology.

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study

F. Carrat, S. Pol, P. Cacoub, 2015, Liver international : official journal of the International Association for the Study of the Liver.

[Non-invasive evaluation of liver fibrosis in hepatitis C].

V. de Lédinghen, T. Poynard, É. Rosenthal, 2008, Gastroenterologie clinique et biologique.

Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.

Y. Sterkers, P. Cacoub, P. Halfon, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort).

C. Protopopescu, T. Barré, P. Carrieri, 2022, AIDS education and prevention : official publication of the International Society for AIDS Education.

pulmonary arterial hypertension Pregnancy and contraception in heart disease and and

N. Panay, C. Nelson-Piercy, F. Walker, 2006 .

Manifestations osseuses du syndrome des antiphospholipides

D. D'cruz, M. Khamashta, S. Sangle, 2007 .

Severe transaminitis after interferon–ribavirin therapy in HIV/HCV‐coinfected patients: influence of a sustained HCV response

F. Carrat, S. Pol, P. Cacoub, 2012, Journal of viral hepatitis.

Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.

Y. Yazdanpanah, F. Carrat, S. Pol, 2008, AIDS.

Obesity in autoimmune diseases: not a passive bystander.

Y. Shoenfeld, P. Jeandel, É. Rosenthal, 2014, Autoimmunity reviews.

Persistently normal alanine aminotransferase levels in HIV/HCV‐coinfected patients: the role of steatosis

F. Carrat, S. Pol, P. Cacoub, 2009, HIV medicine.

High Response Rate to Darbopoetin Alfa in “Low Risk” MDS : Results of a Phase II Study.

L. Mannone, P. Fenaux, C. Gardin, 2004 .

Hepatitis C in France: A national survey in the departments of Internal Medicine and Infectious Diseases

J. Piette, P. Cacoub, É. Rosenthal, 1998, European Journal of Epidemiology.

Primary systemic vasculitis: treatment of difficult cases

S. Sangle, É. Rosenthal, S. Marques, 2006, Lupus.

High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.

J. Izopet, L. Meyer, F. Bailly, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New insights into the pathogenesis of anti-Ro antibody associated congenital complete heart block

É. Rosenthal, 1998, Lupus.

Lack of transmission of hepatitis C virus in very close family contacts of patients undergoing multitransfusions for thalassemia.

É. Rosenthal, A. Koren, A. Hazani, 1999, Journal of pediatric gastroenterology and nutrition.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

[Disseminated Penicillium marneffei infection suggesting visceral leishmaniasis in an HIV infected patient].

J. Cassuto, É. Rosenthal, P. Marty, 2000, Presse medicale.

Treatment of visceral leishmaniasis: a review of current treatment practices

É. Rosenthal, P. Marty, 2002, Expert opinion on pharmacotherapy.

Cytology of peritoneal leishmaniasis in a patient with AIDS.

É. Rosenthal, C. Perrin, P. Marty, 2003, Acta cytologica.

Azathioprine shock.

É. Rosenthal, 1986, Postgraduate medical journal.

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Shyam Sundar, Marleen Boelaert, Caryn Bern, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin.

É. Rosenthal, P. Marty, B. Taillan, 1992, The European journal of medicine.

Leishmania in bronchoalveolar lavage.

A. Pesce, É. Rosenthal, P. Marty, 1991, Annals of internal medicine.

[Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine].

J. Ortonne, I. Bodokh, J. Lacour, 1992, Therapie.

Leishmania/HIV co-infection in south-western Europe 1990-1998 Retrospective analysis of 965 cases

G. Sirera, M. Gramiccia, F. Pratlong, 2000 .

Progressive familial intrahepatic cholestasis among the Arab population in Israel.

H. Mandel, M. Berant, Y. Naveh, 1997, Journal of pediatric gastroenterology and nutrition.

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.

F. Carrat, P. Morlat, S. Pol, 2010, Journal of hepatology.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

F. Carrat, C. Degott, S. Pol, 2004, JAMA.

S. Pol, C. Michelet, C. Pradier, 2007, Journal of viral hepatitis.

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.

D. Neau, S. Pol, Y. Le Strat, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.

F. Dabis, P. Carrieri, É. Rosenthal, 2011, Vaccine.

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)

P. Morlat, S. Pol, C. Pradier, 2003, AIDS.

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

P. Cacoub, É. Rosenthal, C. Perronne, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

P. Morlat, D. Costagliola, G. Chêne, 2014, AIDS.

[HIV and hepatitis C virus coinfection].

S. Pol, D. Sène, P. Cacoub, 2008, Gastroenterologie clinique et biologique.

Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy

F. Carrat, S. Pol, P. Cacoub, 2005, Journal of acquired immune deficiency syndromes.

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

F. Carrat, S. Pol, N. Lapidus, 2008, AIDS.

Use of first‐generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

S. Pol, P. Cacoub, G. Pialoux, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases

M. Boubaya, J. Viallard, L. Galicier, 2016, American journal of hematology.

É. Oksenhendler, P. Morlat, D. Costagliola, 2015, PloS one.

[Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].

P. Jeandel, É. Rosenthal, P. Marty, 2009, Medecine et maladies infectieuses.

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.

D. Costagliola, S. Grabar, C. Pradier, 2002, The Journal of infectious diseases.

A century of leishmaniasis in Alpes-Maritimes, France

F. Pratlong, M. Gari-Toussaint, É. Rosenthal, 2007, Annals of tropical medicine and parasitology.

[Therapy of leishmaniasis in France: consensus on proposed guidelines].

L. Lachaud, P. Couppié, J. Dedet, 2011, Presse medicale.

HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania.

J. Cassuto, C. Pradier, É. Rosenthal, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Coexistence of celiac disease and eosinophilic gastroenteropathy.

I. Amirav, G. Gleich, Y. Naveh, 2001, Journal of pediatric gastroenterology and nutrition.

[Visceral leishmaniasis associated with Wegener disease. Use of lipid complex amphotericin B and liposomal amphotericin B].

A. Pesce, J. Cassuto, É. Rosenthal, 1999, Presse medicale.

Spectrum of conduction abnormalities associated with maternal anti-Ro antibodies

É. Rosenthal, 2002, Lupus.

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

P. Morlat, D. Costagliola, C. Lewden, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Noninvasive Procedures to Evaluate Liver Involvement in HIV-1 Vertically Infected Children

A. Tran, F. Monpoux, É. Rosenthal, 2009, Journal of pediatric gastroenterology and nutrition.

Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).

P. Morlat, D. Costagliola, C. Lewden, 2010, International journal of epidemiology.

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

M. Guiguet, D. Costagliola, É. Rosenthal, 2009, The Lancet. Oncology.

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS (London).

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS.

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.

D. Neau, P. Morlat, F. Dabis, 2017, Journal of hepatology.

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009.

Y. Yazdanpanah, J. Pawlotsky, S. Pol, 2010, Journal of hepatology.

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)‐coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]

D. Neau, P. Morlat, B. Spire, 2016, HIV medicine.

Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.

S. Pol, P. Cacoub, G. Pialoux, 2008, Journal of hepatology.

Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life

S. Pol, D. Sène, P. Cacoub, 2006, Journal of viral hepatitis.

Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.

Y. Naveh, É. Rosenthal, D. Berkowitz, 2000, Journal of pediatric gastroenterology and nutrition.

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.

D. Neau, P. Morlat, F. Dabis, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients

J. Rockstroh, F. Dabis, P. Sogni, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.

L. Garbe, A. Pesce, J. Michiels, 1993, Transplantation proceedings.

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.

F. Dabis, F. Raffi, M. Carrieri, 2017, Journal of hepatology.

No significant effect of cannabis use on the count and percentage of circulating CD4 T‐cells in HIV‐HCV co‐infected patients (ANRS CO13‐HEPAVIH French cohort)

F. Dabis, M. Carrieri, C. Protopopescu, 2017, Drug and alcohol review.

Recent understanding in the treatment of visceral leishmaniasis.

É. Rosenthal, P. Marty, 2003, Journal of postgraduate medicine.

Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases.

J. Cassuto, É. Rosenthal, P. Marty, 2000, Annals of tropical medicine and parasitology.

Assessment of thoracic ultrasound in complementary diagnosis and in follow up of community-acquired pneumonia (cap)

Vincenzo Carnevale, Maria D’Amato, Gaetano Rea, 2017, BMC Medical Imaging.

Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases

J. Cassuto, É. Rosenthal, P. Marty, 2000 .

HIV and Leishmania Coinfection: A R eview o f 9 1 Cases w ith F ocus o n A typical L ocations o f Leishmania

É. Rosenthal, 2000 .

Preexposure prophylaxis (PrEP) of HIV infection in France: A nationwide cross-sectional study (PREVIC study)

C. Pradier, P. Cacoub, L. Cotte, 2014, AIDS care.

Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians

C. Mussini, P. Cacoub, V. Puro, 2017, BMC Infectious Diseases.

Changes in Sexual Behaviors in Men Who Have Sex with Men: A Comparison Between the Double-Blind and Open-Label Extension Phases of the ANRS-IPERGAY Trial

C. Delaugerre, A. Chamberland, H. Melliez, 2020, AIDS and Behavior.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

M. Wainberg, C. Delaugerre, C. Tremblay, 2018, Open forum infectious diseases.

Prevalence, characteristics and prognostic significance of anemia in daily practice.

E. Hachulla, F. Bonnet, P. Cacoub, 2012, QJM : monthly journal of the Association of Physicians.

Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection.

V. Giordanengo, É. Rosenthal, B. Dunais, 2015, World journal of hepatology.

Infection Rate and Bacterial Spectrum in 413 Patients of a Neurosurgical Intensive Care Unit: Results of a 2-Year Prospective Study

R. Kalff, É. Rosenthal, W. Grote, 1991 .

Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy.

J. Cassuto, C. Pradier, P. Desjeux, 2001, AIDS.

Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis

S. Qureshi, J. Simpson, C. Austin, 2001, Archives of disease in childhood.

[Kaposi disease and sex hormones: apropos of a case, review of the literature].

A. Pesce, J. Cassuto, É. Rosenthal, 1994, La Revue de medecine interne.

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.

C. Katlama, D. Neau, P. Morlat, 2020, Clinical Infectious Diseases.

Changes in the Profile and Care of HIV-HCV Seropositive Patients in TwoCross-Sectional Surveys in France (2006 and 2013)

P. Morlat, S. Pol, P. Cacoub, 2014 .

Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.

F. Carrat, S. Pol, N. Lapidus, 2009, Journal of acquired immune deficiency syndromes.

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)

F. Dabis, M. Carrieri, B. Spire, 2012, BMC Health Services Research.

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.

F. Carrat, S. Pol, P. Cacoub, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C Virus Infection and Cancer Risk among HIV-Infected Individuals

D. Serraino, M. Carrieri, C. Pradier, 2003, Infection.

Lymphoproliferative diseases and hepatitis C virus infection.

P. Cacoub, É. Rosenthal, P. Hausfater, 2000, Annales de medecine interne.

Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.

C. Katlama, D. Neau, P. Morlat, 2019, European journal of gastroenterology & hepatology.

Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients

D. Ouzan, A. Tran, C. Renou, 2008, Alimentary pharmacology & therapeutics.

Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis

G. Hughes, D. D'cruz, M. Khamashta, 2006, Annals of the rheumatic diseases.

Convenience of Serum for Visceral Leishmaniasis Diagnosis by PCR

É. Rosenthal, B. Ferruà, P. Marty, 2004, Journal of Clinical Microbiology.

Isolated lymphadenopathy in Leishmania infantum infection: three case reports

N. Cardot-Leccia, G. Cenderello, É. Rosenthal, 2009, Annals of tropical medicine and parasitology.

Hepatopulmonary syndrome associated with visceral leishmaniasis

P. Jeandel, N. Martis, T. Lazure, 2015, Immunologic research.

Hepatopulmonary syndrome associated with visceral leishmaniasis

P. Jeandel, N. Martis, T. Lazure, 2014, Immunologic Research.

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono‐infected compared with HIV–HCV co‐infected patients

F. Carrat, D. Ouzan, P. Bedossa, 2009, Alimentary pharmacology & therapeutics.

Introduction to the special issue on the 9th International Congress on Autoimmunity

Y. Shoenfeld, P. Jeandel, É. Rosenthal, 2014, Immunologic research.

Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group.

J. Piette, D. Ouzan, P. Cacoub, 2000, American journal of hematology.

Cutaneous spindle-cell pseudotumors due to Mycobacterium gordonae and Leishmania infantum. An immunophenotypic study.

É. Rosenthal, C. Perrin, P. Hofman, 1993, The American Journal of dermatopathology.

Classification of congenital complete heart block: autoantibody-associated or isolated?

É. Rosenthal, 2003, Lupus.

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

V. de Lédinghen, Y. Yazdanpanah, D. Neau, 2018, HIV medicine.

Efficacy , safety and patient-reported outcomes of ledipasvir / sofosbuvir in NS 3 / 4 A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis ( ANRS HC 31 SOFTRIH study )

M. Dupon, P. Morlat, T. Allègre, 2019 .

P643 Causes of liver related death in HIV-infected patients in France: mortality 2005 Survey

P. Morlat, D. Costagliola, C. Lewden, 2007 .

PREVALENCE DES ANTICORPS DIRIGES CONTRE LE VIRUS DE L'HEPATITE C DANS UNE POPULATION DU SUD-EST DE LA FRANCE INFECTEE PAR LE VIH

A. Pesce, J. Cassuto, É. Rosenthal, 1991 .

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

P. Campbell, T. Pearson, M. Polkey, 2005, British journal of haematology.

Extrahepatic Manifestations Associated with Hepatitis C Virus Infection: A Prospective Multicenter Study of 321 Patients

J. Piette, A. Camproux, L. Musset, 2000 .

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir

J. Molina, A. Chéret, V. Furlan, 2015, Antimicrobial Agents and Chemotherapy.